Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial
- 5 October 2009
- journal article
- review article
- Published by Elsevier BV in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 34 (1), 76-80
- https://doi.org/10.1016/j.pnpbp.2009.09.026
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The neurobiology of attention deficit/hyperactivity disorderEuropean Journal of Paediatric Neurology, 2009
- Attention‐Deficit‐Hyperactivity Disorder: An UpdatePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Attention Deficit/Hyperactivity Disorder: A Review and UpdateJournal of Pediatric Nursing, 2008
- Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trialProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy peopleHuman Psychopharmacology: Clinical and Experimental, 2007
- Psychometric properties of the Farsi translation of the kiddie schedule for affective disorders and schizophrenia-present and lifetime versionBMC Psychiatry, 2006
- Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescentsTherapy, 2005
- Non?stimulant medications in the treatment of ADHDEuropean Child & Adolescent Psychiatry, 2004
- Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]BMC Psychiatry, 2004
- Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trialProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003